Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CJ-12420 in Erosive Esophagitis (Phase 3, Double-Blind, Randomized, Active-Controlled)
KCT0001828Phase 3Recruiting
- Sponsor
- HK inno.N Corporation
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tegoprazan in erosive esophagitis (EE) (2 arms), sponsored by HK inno.N Corporation. Started May 2015; status: recruiting.
02
Drugs
tegoprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on KCT0001828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001828.